First FDA-Approved Modular System for Infected Total Joints Launched by OsteoRemedies

Share Article

OsteoRemedies®, LLC, today announced availability of the first FDA-approved modular system for two-staged revisions of infected hip and knee arthroplasty.

OsteoRemedies logo

The REMEDY® Spacer saves the surgeon and the facility valuable time compared to traditional revision infection procedures.

OsteoRemedies®, LLC, Memphis, TN, offers the first FDA-approved modular system for two-stage revision of infected hip and knee arthroplasty.

The REMEDY® Spacer is sterile-packaged as a pre-formed, pre-loaded spacer with Gentamicin Antibiotics, for consistent and reliable elution to the infected joint space. Combined with a consistent process for polishing the PMMA articulating surfaces, the REMEDY® spacer is approved for temporary use for up to 180 days.

As a pre-packaged solution, the REMEDY® Spacer also saves the surgeon and the facility valuable time compared to traditional revision infection procedures.

The system enables surgeons to appropriately address a patient’s anatomy with complete interchangeability between femoral and tibial knee sizing for knee revisions, and a fully modular femoral head and stem design for hip revisions.

Contact OsteoRemedies® at 1-800-OSTEO-XL(800-678-3695) or http://www.osteoremedies.com to schedule a surgery or for more information. OsteoRemedies® is focused on providing simple solutions to complex disorders currently not addressed in the musculoskeletal market.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bill Hornung
Visit website